Cost-effectiveness of early treatment of ACPA-positive rheumatoid arthritis patients with abatacept. [electronic resource]
Producer: 20180731Description: 448-454 p. digitalISSN:- 0392-856X
- Abatacept -- economics
- Adalimumab -- economics
- Anti-Citrullinated Protein Antibodies -- immunology
- Antirheumatic Agents -- economics
- Arthritis, Rheumatoid -- drug therapy
- Cost-Benefit Analysis
- Decision Trees
- Drug Costs
- Early Medical Intervention
- Etanercept -- economics
- Germany
- Humans
- Infliximab -- economics
- Methotrexate -- economics
- Remission Induction
- Rituximab -- economics
- Treatment Failure
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.